Zivo Bioscience (ZIVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 346 | 389 | 317 | 507 | 17 |
| TOTAL | $369 | $412 | $332 | $520 | $29 |
| Non-Current Assets | |||||
| PPE Net | 0 | N/A | N/A | 19 | 44 |
| Other Non-Current Assets | 0 | 0 | 0 | 198 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $217 | $44 |
| Total Assets | $369 | $412 | $332 | $737 | $73 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,653 | 18,577 | 2,426 | 7,799 | 2,676 |
| Accrued Expenses | 1,953 | 3,674 | 1,649 | 2,660 | 1,673 |
| Other current liabilities | N/A | 432 | 476 | 319 | 211 |
| TOTAL | $8,708 | $22,694 | $4,561 | $11,183 | $4,971 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 12,076 | 3,176 | 4,599 |
| TOTAL | $N/A | $N/A | $12,076 | $3,176 | $4,599 |
| Total Liabilities | $8,708 | $22,694 | $16,637 | $14,359 | $9,570 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 838 | 375 | 294 | N/A | N/A |
| Common Shares | 397 | 180 | 141 | 137 | 132 |
| Retained earnings | -89,958 | -78,448 | -63,812 | -53,774 | -47,714 |
| TOTAL | $-8,339 | $-22,282 | $-16,305 | $-13,621 | $-9,497 |
| Total Liabilities And Equity | $369 | $412 | $332 | $737 | $73 |